We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Sunday
May 08
16:55 - 17:55
Auditorium 11
Prostate, head & neck, eye
Ann Henry, United Kingdom;
Luca Tagliaferri, Italy
Proffered Papers are presented at one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be streamed.
Proffered Papers
Brachytherapy
16:55 - 16:56
Presentation of ESTRO-Elekta Brachytherapy Award
16:56 - 17:05
ESTRO-Elekta Brachytherapy Award: HDR brachytherapy boost improves metastatic free survival in high and very-high risk prostate cancer
Ignacio Visus, Spain
OC-0611
17:05 - 17:15
Recurrence characteristics in prostate cancer patients after (salvage) focal HDR brachytherapy
Max Peters, The Netherlands
OC-0612
17:15 - 17:25
Pre-treatment Neutrophil to Lymphocyte Ratio predicts Overall Survival in Prostate Brachytherapy
Sofia Garcia, Portugal
OC-0613
17:25 - 17:35
HDR-BT for primary tumors and relapses after surgery in patients with BCC of the H&N region.
Artur Chyrek, Poland
OC-0614
17:35 - 17:45
Results of sole postoperative interstitial, high-dose-rate brachytherapy of tongue tumours
Zoltan Takacsi-Nagy, Hungary
OC-0615
17:45 - 17:55
Local control, metastasis and visual function after brachytherapy in choroidal melanoma.
Mercedes Gonzalez Cantero, Spain
OC-0616